Year |
Place |
Speaker |
Title |
2022 |
Freiburg |
Prof Dr B Plecko |
On pathways and blind alleys |
2021 |
Virtual meeting |
Prof K Ounap |
The identification of new rare metabolic diseases: an example of the tremendous impact on Estonia’s detection rate by new technologies |
2020 |
Virtual meeting |
Prof E Van Schaftingen |
Elucidating the causes of metabolic disorders: the new veins to explore |
2019 |
Rotterdam |
Dr C Vianey-Saban |
From fatty acid oxidation to riboflavin Make metabolites great again |
2018 |
Athens |
Prof P T Clayton |
Restoring missing metabolites: from bile to acid to B6 |
2016 |
Rome |
Prof M Zeviani |
Mitochondrial Disorders, a journey through the magic circle and beyond |
2015 |
Lyon |
Prof B T Poll-The |
Peroxisomal disorders and more…: Why I have not stopped examining patients |
2014 |
Innsbruck |
Prof G Brown |
A wide circle around lactic acid |
2013 |
Barcelona |
Dr C Dionisi-Vici |
The daily challenge of understanding and treating metabolic disorders in children |
2012 |
Birmingham |
Prof R J A Wanders |
Inborn errors of metabolism including peroxisomal diseases in a changing world of omics and systems biology |
2011 |
Geneva |
Dr M T Vanier |
Lysosomal neurolipidoses: the enigmas and the challenges |
2010 |
Istanbul |
Prof B Wilcken |
Newborn Screening: How are we travelling? Where we might get to? |
2008 |
Lisbon |
Prof N Gregersen |
Mitochondrial fatty acid oxidation defects, remaining challenges |
2007 |
Hamburg |
Prof W S Sly |
Evolution of therapy for lysosomal diseases |
2005 |
Paris |
Prof J Leonard |
The treatment of inborn errors of metabolism |
2004 |
Amsterdam |
Prof M Gibson |
Gamma-hydroxybutyric aciduria: a biochemist’s education from a heritable disorder of GABA metabolism |
2002 |
Dublin |
Prof J Jaeken |
Congenital disorders of glycosylation: its all in it |
2001 |
Prague |
Prof H Galjaard |
New names for old disciplines |
1999 |
Genova |
Prof J M Saudubray |
Genetic hypoglycaemia |
1998 |
York |
Prof D Valle |
Ornithine metabolism, metabolic network and normal biology |
1997 |
Gothenburg |
Prof S J Segal |
Galactosaemia today: the enigma and the challenge |
1996 |
Cardiff |
Dr A M Spiegel |
Inborn errors of signal transduction mutations in G Protein-coupled receptors as a cause of disease |
1995 |
Toledo |
Dr G Salem |
Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome |
1994 |
Edinburgh |
Prof H W Moser |
Adrenoleukodystrophy, natural history, treatment and outcome |
1993 |
Manchester |
Prof J P Kraus |
Molecular basis of phenotype expression in homocystinuria |